CNS involvement in Ewing's sarcoma
โ Scribed by Yashbir Mehta; Frank R. Hendrickson
- Publisher
- John Wiley and Sons
- Year
- 1974
- Tongue
- English
- Weight
- 313 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Between 1984Between -1987, 50 , 50 patients with Ewing's sarcoma of the bone were entered on combined modality protocol at Tata Memorial Hospital. Protocol treatment involved induction therapy consisting of 6-week therapy with vincristine, Adriamycin (doxorubicin), and cyclophosphamide (VDC) follow
## Background: Ewing's sarcoma usually is identified as a primary malignancy of bone affecting children and young adults. extraskeletal ewing's sarcoma is rare, and very few data are available addressing optimal surgical and oncologic treatment modalities. ## Methods: The authors chose to review
Adjuvant chemotherapy using vincristine, cyclophosphamide, and adriamycin was used in 28 patients with localized Ewing's sarcoma. Life-table analysis revealed 55% disease-free survival at 3 years. In contrast, our historical control showed less than 10% long-term survival. Adjuvant chemotherapy appe